Our data elucidate the oncogenic and drug-resistant role of NAT10 in HCC and highlight the importance of ac4C modification as a novel gene epigenetic regulatory pathway in tumor development, providing new insights into further mechanisms of tumorigenesis and progression. This evidence concerns the gene NAT10 and neoplasm.